AzTrials
AzTrials

ObesityALRESPGHOBNCT05759598

Effect of Respiratory Training Protocols on GH Secretion in Obesity (ALRESPGHOB)

A study testing Rehabilitation protocol + guided spontaneous breathing exercises and Rehabilitation protocol + specific respiratory muscle training program in people with Obesity, run by Istituto Auxologico Italiano at 1 site in Italy.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The study's primary objective is to evaluate the acute and chronic (3 weeks) effects of two respiratory training protocols in obese adolescents (performed during a period of hospitalization for a body weight reduction program), with different characteristics and mechanisms of action, on GH and IGF-I secretion. Read more about this study

Who is it for?
Ages 14 to 30 years, men only
Conditions the study is for
Obesity
What is being tested?
Rehabilitation protocol + guided spontaneous breathing exercises and Rehabilitation protocol + specific respiratory muscle training program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3 participants
Where
1 siteItaly
Study dates
14 Oct 2021to 8 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 30 years
  • Men only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • BMI standard deviation score (SDS) > 2 for subjects aged < 18 years and BMI > 35 for patients aged >18 years;
  • absence of structured physical activity programs (regular activity for more than 120 minutes/week) during the 6 months preceding the study;
  • absence of signs/symptoms referable to cardiovascular, respiratory, gastrointestinal, or musculoskeletal pathologies contraindicated for carrying out the tests.

Who cannot join

  • age < 14 years and > 30 years;
  • presence of structured physical activity programs (regular activity for more than 120 minutes/week) during the 6 months preceding the study;
  • presence of signs/symptoms referable to cardiovascular, respiratory, gastrointestinal, or musculoskeletal pathologies contraindicated for carrying out the tests.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Istituto Auxologico Italiano, Site Piancavallo

    Oggebbio, Verbania, 28824

Other trials in Italy

About this study

Official title: Effect of Respiratory Training Protocols on GH Secretion in the Obese Patient

The study's primary objective is to evaluate the acute and chronic (3 weeks) effects of two respiratory training protocols in obese adolescents (performed during a period of hospitalization for a body weight reduction program), with different characteristics and mechanisms of action, on GH and IGF-I secretion. The definition of the protocols is based on what has been observed by recent studies conducted on healthy people (Wuthrich et al., 2015; Schaer et al., 2018) and on patient populations in which respiratory dysfunction is a primary or secondary component of the pathology (Calcaterra et al., 2014; Pomidori et al., 2009). All planned interventions are safe and are adapted to the obese patient.

Project objectives are:

  • assessment of GH-IGF-I responses (baseline), during the first training session of the respiratory muscles conducted in the first days of hospitalization of the patients in the clinic
  • assessment of GH-IGF-I responses (post), during the last training session of the respiratory muscles conducted at the end of the three weeks of each training session
Read the detailed description

Materials and methods:

Subjects The study provides for the recruitment of 20 obese boys/young adults aged between 14 and 30 years old hospitalized at the Division of Auxology and the Division of Metabolic Diseases, Istituto Auxologico Italiano, S. Giuseppe Hospital, Piancavallo (VB).

Criteria for inclusion in the study group are:

  1. BMI standard deviation score (SDS)>2 for patients < 18 years and BMI>35 for patients aged>18 years;
  2. absence of structured physical activity programs (regular activity for more than 120 minutes/week) during the 6 months preceding the study;
  3. absence of signs/symptoms referable to cardiovascular, respiratory, gastrointestinal, or musculoskeletal pathologies contraindicated for carrying out the tests.

Materials and methods:

During the first respiratory training session (basal) and at the end of the three weeks of hospitalization (post) for an integrated metabolic rehabilitation program at the Division of Auxology (patients aged < 18 years) and Division and Metabolic Diseases (adults) a blood sample is taken from each subject to determine the circulating levels of GH (total and isoforms 20 kDa and 22kDa) and cortisol in pre-training conditions and at times 0 ' (immediately at the end), +15', +30' and +60' (IGF-I levels are determined only in pre-workout conditions and immediately at the end). Blood samples taken after training are carried out by needle cannula during a saline infusion, to reduce the number of venipunctures. Lactate levels are determined by earlobe puncture in basal conditions, immediately at the end of the training session, and repeated every 2 minutes, until the peak value is reached.

In baseline conditions and at the end of the 3 weeks of respiratory training, body composition is evaluated (by impedance analysis), the maximum force developed during voluntary isometric contraction of the extensor and flexor muscles of the lower limb (by dynamometer), and spirometry is performed for the assessment of maximal lung capacity.

Respiratory muscle training protocol:

The recruited subjects are randomly divided into two homogeneous groups in terms of the number and basic characteristics of the subjects. A control group (CTRL) carries out the standard integrated metabolic rehabilitation protocol with the addition of guided spontaneous breathing exercises lasting about 20 minutes per session for 12 sessions.

An experimental group (RMT) carries out, in addition to the standard integrated metabolic rehabilitation protocol, a specific respiratory muscle training program according to the protocol recently proposed by Spengler et al. (Wuthrich et al., 2015; Schaer et al., 2018), adapted according to the baseline characteristics of the respiratory function of the subjects. The protocol includes 12 interval breathing training sessions, divided into 3 weeks (4 sessions/week) each lasting a total of about 12 minutes. Each respiratory training session includes 6 1-minute "sprint" breathing intervals followed by 1 minute of recovery. During the sprint intervals, the subjects breathe through a dedicated SpiroTiger instrument (Idiag AG, Fehraltorf, Switzerland) with the addition of a resistance (Schaer et al., 2018) which allows normocapnic hyperpnea against resistance. Subjects are asked to breathe at a respiratory rate of 25-30 breaths/minute with a constant tidal volume corresponding to approximately 60% of forced vital capacity. The target frequency is adjusted on an individual basis and is defined during the initial familiarization trials.

Conditions
Obesity
Being tested
Rehabilitation protocol + guided spontaneous breathing exercises, Rehabilitation protocol + specific respiratory muscle training program
Keywords
Growth hormone, Insulin-like growth factor, Training of respiratory muscles
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rehabilitation protocol + guided spontaneous breathing exercisesOther

    Standard integrated metabolic rehabilitation protocol + guided spontaneous breathing exercises

  • Rehabilitation protocol + specific respiratory muscle training programOther

    Standard integrated metabolic rehabilitation protocol + specific respiratory muscle training program according to the protocol recently proposed by Spengler et al. (Wuthrich et al., 2015; Schaer et al., 2018), adapted according to the baseline characteristics of the respiratory function of the subjects

Study groups in NCT05759598
Study groupRoleWhat they receive
Control group (CTRL)OtherNot described
Receives: Other: Rehabilitation protocol + guided spontaneous breathing exercises
Experimental group (RMT)ExperimentalNot described
Receives: Other: Rehabilitation protocol + specific respiratory muscle training program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Growth hormone (GH)

    Change in plasma concentration of growth hormone

    Measured: Baseline, 0, 15, 30 and 45 minutes after Intervention and 3 weeks after intervention

  2. Insulin-like growth factor (IGF-I)

    Change in plasma concentration of insulin-like growth factor

    Measured: Baseline and 0 minutes after Intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Mar 2023
  2. Study start14 Oct 2021
  3. Primary completion8 Jun 2022
  4. Study completion8 Jun 2022

Why it stopped: Lack of hormonal responses (GH) in response to the respiratory training protocols in the three subjects tested.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
3 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05759598
Sponsor's protocol ID
01C020
Acronym
ALRESPGHOB
Status last verified
Mar 2023
First submitted
26 Feb 2023
Last updated
9 Mar 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Rehabilitation protocol + guided spontaneous breathing exercises and Rehabilitation protocol + specific respiratory muscle training program in people with Obesity, run by Istituto Auxologico Italiano at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 9 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Lack of hormonal responses (GH) in response to the respiratory training protocols in the three subjects tested.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Growth hormone (GH) (time frame: Baseline, 0, 15, 30 and 45 minutes after Intervention and 3 weeks after intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in